Yellow Fever: Factors Associated with Death in a Hospital of Reference in Infectious Diseases, São Paulo, Brazil, 2018
Authors:
- Ana Freitas RibeiroARAna Freitas Ribeiro
- Roberta Figueiredo CavalinRCRoberta Figueiredo Cavalin
- Jamal Muhamad Abdul Hamid SuleimanJSJamal Muhamad Abdul Hamid Suleiman
- Jessica Alves da CostaJCJessica Alves da Costa
- Marileide Januaria de VasconcelosMVMarileide Januaria de Vasconcelos
- Ceila Maria Sant’ana MálaqueCMCeila Maria Sant’ana Málaque
- Jaques SztajnbokJSJaques Sztajnbok
- 3 July 2019
- journal article
- research article
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 101 (1) , 180-188
Abstract
Faced with the reemergence of yellow fever (YF) in the metropolitan region of São Paulo, Brazil, we developed a retrospective study to describe the cases of YF attended at the Institute of Infectology Emilio Ribas from January to March 2018 and analyze the factors associated with death, from the information obtained in the hospital epidemiological investigation. A total of 72 cases of sylvatic YF were confirmed, with 21 deaths (29.2% lethality rate). Cases were concentrated in males (80.6%) and in the age group of 30 to 59 years (56.9%). Two logistic regression models were performed, with continuous variables adjusted for the time between onset of symptoms and hospitalization. The first model indicated age (odds ratiosadjusted [ORadj]: 1.038; CI 95%: 1.008–1.212), aspartate aminotransferase (AST) (ORadj: 1.038; CI 95%: 1.005–1.072), and creatinine (ORadj: 2.343; CI 95%: 1.205–4.553) were independent factors associated with mortality. The second model indicated age (ORadj: 1.136; CI 95%: 1.013–1.275), alanine aminotransferase (ALT) (ORadj: 1.118; CI 95%: 1.018–1.228), and creatinine (ORadj: 2.835; CI 95%: 1.352–5,941). The risk of death in the model with continuous variables was calculated from the increase of 1 year (age), 1 mg/dL (creatinine), and 100 U/L for AST and ALT. Another logistic regression analysis with dichotomous variables indicated AST > 1,841 IU/L (ORadj: 12.92; CI 95%: 1.50–111.37) and creatinine > 1.2 mg/dL (ORadj: 81.47; CI 95%: 11.33–585.71) as independent factors associated with death. These results may contribute to the appropriate clinical management of patients with YF in health-care services and improve the response to outbreaks and public health emergencies.Keywords
This publication has 24 references indexed in Scilit:
- The whole iceberg: estimating the incidence of yellow fever virus infection from the number of severe casesTransactions of the Royal Society of Tropical Medicine and Hygiene, 2014
- Febre amarela silvestre: reemergência de transmissão no estado de São Paulo, Brasil, 2009Revista de Saúde Pública, 2013
- Determinants of Mortality from Severe Dengue in Brazil: A Population-Based Case-Control StudyThe American Journal of Tropical Medicine and Hygiene, 2013
- Yellow fever vaccine2013
- Advanced Yellow Fever Virus Genome Detection in Point-of-Care Facilities and Reference LaboratoriesJournal of Clinical Microbiology, 2012
- Evolução histórica da vigilância epidemiológica e do controle da febre amarela no BrasilRevista Pan-Amazônica de Saúde, 2011
- Hepatocyte lesions and cellular immune response in yellow fever infectionTransactions of the Royal Society of Tropical Medicine and Hygiene, 2007
- Clinical and epidemiological characteristics of yellow fever in Brazil: analysis of reported cases 1998–2002Transactions of the Royal Society of Tropical Medicine and Hygiene, 2007
- Febre amarelaRevista da Sociedade Brasileira de Medicina Tropical, 2003
- Experimental Yellow Fever Virus Infection in the Golden Hamster(Mesocricetus auratus).I. Virologic, Biochemical, and Immunologic StudiesThe Journal of Infectious Diseases, 2001